Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
NEO

Market Cap: $445.04M

NI

NeoGenomics, Inc.

NEO

NASDAQ (NASDAQ Capital Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin42.92%

EBITDA Margin1.68%

EBIT Margin-6.86%

Pre-tax Margin-7.12%

Net Profit Margin-6.77%

Earnings Yield-11.55%

Valuation Multiples

Price / Book0.57

Price / Sales0.58

Price / Earnings-8.73

PEG-0.16

Forward PEG-0.10

EV / Sales0.98

EV / EBITDA58.04

EV / Operating Cash Flow33.92

EV / Free Cash Flow-101.68

Price / Free Cash Flow-60.51

Price / Operating Cash Flow20.37

Cash Flow & Capital

Free Cash Flow / Share-$0.28

Operating Cash Flow / Share$0.85

Free Cash Flow Yield-1.65%

Capex / Revenue3.84%

Capex / Operating Cash Flow1.33%

Capex / Depreciation0.45

Stock Compensation / Revenue3.67%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.60

Quick Ratio3.35

Cash Ratio1.37

Debt / Assets0.33

Debt / Capital0.36

Debt / Equity0.57

Long-Term Debt / Capital0.32

Debt / Market Cap85.31%

Net Debt / EBITDA23.50

Solvency Ratio0.02

Financial Leverage1.72

Efficiency & Working Capital

Asset Turnover0.57

Fixed Asset Turnover4.61

Inventory Turnover16.12

Receivables Turnover4.37

Payables Turnover4.35

Days Sales Outstanding83.55

Days Inventory Outstanding22.65

Days Payables Outstanding83.83

Operating Cycle106.19

Cash Conversion Cycle22.36

Working Capital Turnover2.71

Returns & Quality

Return on Equity-6.31%

Return on Assets-3.84%

Return on Invested Capital-5.03%

ROCE-5.31%

Return on Tangible Assets-9.31%

Operating Return on Assets-4.90%

Income Quality-0.43

Tax Burden0.95

Interest Burden1.04

Balance Sheet & Intrinsic Metrics

Enterprise Value$747.87M

Invested Capital$1.24B

Working Capital$275.6M

Tangible Asset Value$-8.66M

Net Current Asset Value$-184.17M

Graham Net-Net-$10.61

Book Value / Share$30.34

Tangible Book Value / Share-$0.33

Cash / Share$5.61

Financial Health Scores

Piotroski Score4

Altman Z-Score0.69

Revenue$766.3M

EBIT$-52.57M

Market Cap$445.27M

Working Capital$275.6M

Retained Earnings$-448.67M

Total Assets$1.35B

Total Liabilities$565.65M